Paolo Agnoluzzi

Chief Financial Officer


Mr. Paolo Agnoluzzi has been appointed Chief Financial Officer, effective June 1st, 2017. Mr. Agnoluzzi joined EffRx in August 2016 as Interim Chief Financial Officer and led the re-organization of the Finance Department. Among other achievements, he executed a number of debt and equity transactions, including a capital increase.

Most recently, Mr. Agnoluzzi served as Finance Director for VistaJet Group Holding SA. His responsibilities included acting as deputy CFO, leading the financial planning and analysis group, heading the treasury function and directing special projects within Finance.

Prior to VistaJet, Mr. Agnoluzzi held the position of Director Finance Europe and Commercial Head DACH Region at Endocyte Europe GmbH. Previously to Endocyte, he spent 20 years at Amgen serving various senior financial positions, including among others, Head of Finance Oncology, Bone and New Products and Director Finance & Administration.